NMR methods in fragment based drug discovery

被引:0
|
作者
Lim, Jongsoo [1 ]
机构
[1] Innovat Med Res Labs, Mol Pharmacol Team, 21 Geumhwa Ro 105 Beon Gil, Yongin 446905, Gyeonggi Do, South Korea
来源
JOURNAL OF THE KOREAN MAGNETIC RESONANCE SOCIETY | 2015年 / 19卷 / 03期
关键词
FBDD; HTS; NMR; Fragment library quality control;
D O I
10.6564/JKMRS.2015.19.3.132
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear magnetic resonance (NMR) spectroscopy, owing to its ability to provide atomic level information on molecular structure, dynamics and interaction, has become one of the most powerful methods in early drug discovery where hit finding and hit-to-lead generation are mainly pursued. In recent years, drug discovery programs originating from the fragment-based drug discovery (FBDD) strategies have been widely incorporated into academia and industry in which a wide variety of NMR methods become an indispensable arsenal to elucidate the binding of small molecules onto bimolecular targets. In this review, I briefly describe FBDD and introduce NMR methods mainly used in FBDD campaigns of my company. In addition, quality control of fragment library and practical NMR methods in industrial aspect are discussed shortly.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 50 条
  • [11] Introduction to Fragment-Based Drug Discovery
    Erlanson, Daniel A.
    FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY, 2012, 317 : 1 - 32
  • [12] Fragment-based drug discovery as alternative strategy to the drug development for neglected diseases
    Rezende e Mello, Juliana da Fonseca
    Gomes, Renan Augusto
    Vital-Fujii, Drielli Gomes
    Ferreira, Glaucio Monteiro
    Henrique Goulart Trossini, Gustavo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (06) : 1067 - 1078
  • [13] What is the future for fragment-based drug discovery?
    Keseru, Gyorgy M.
    Hann, Michael M.
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (13) : 1457 - 1460
  • [14] Advances in fragment-based drug discovery platforms
    Orita, Masaya
    Warizaya, Masaichi
    Amano, Yasushi
    Ohno, Kazuki
    Niimi, Tatsuya
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (11) : 1125 - 1144
  • [15] Fragment-based Drug Discovery: Concept and Aim
    Tanaka, Daisuke
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (03): : 315 - 323
  • [16] Fragment-Based Drug Discovery for RNA Targets
    Lundquist, Kasper P.
    Panchal, Vipul
    Gotfredsen, Charlotte H.
    Brenk, Ruth
    Clausen, Mads H.
    CHEMMEDCHEM, 2021, 16 (17) : 2588 - 2603
  • [17] NMR-based fragment screening and lead discovery accelerated by principal component analysis
    Namanja, Andrew T.
    Xu, Jia
    Wu, Haihong
    Sun, Qi
    Upadhyay, Anup K.
    Sun, Chaohong
    Van Doren, Steven R.
    Petros, Andrew M.
    JOURNAL OF BIOMOLECULAR NMR, 2019, 73 (12) : 675 - 685
  • [18] NMR-based fragment screening and lead discovery accelerated by principal component analysis
    Andrew T. Namanja
    Jia Xu
    Haihong Wu
    Qi Sun
    Anup K. Upadhyay
    Chaohong Sun
    Steven R. Van Doren
    Andrew M. Petros
    Journal of Biomolecular NMR, 2019, 73 : 675 - 685
  • [19] Fragment-based drug discovery using the SHAPES method
    Lepre, Christopher
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (12) : 1555 - 1566
  • [20] Informatics and modeling challenges in fragment-based drug discovery
    Hubbard, Roderick E.
    Chen, Ijen
    Davis, Ben
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2007, 10 (03) : 289 - 297